Human VEGF165 Antibody, R&D Systems™

VEGF

Polyclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor

Goat

Affinity Purified

RUO

7422

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot, Immunohistochemistry, Neutralization, Immunocytochemistry

LYOPH

Western Blot 5-10 ug/mL, Immunohistochemistry 3-15 ug/mL, Neutralization 0.02-0.12 ug/mL, Immunocytochemistry 5-15 ug/mL

NP_001165097.1

VEGFA

S. frugiperdainsect ovarian cell lineSf21-derived recombinant human VEGF 165 Ala27-Arg191 Accession # NP_001165097.1

25 μg

Primary

Detects human VEGF in direct ELISAs and Western blots. In direct ELISAs, approximately 100% cross-reactivity with recombinant canine VEGF is observed, and less than 20% cross-reactivity with recombinant mouse VEGF165 and recombinant rat VEGF164 is observed, and less than 5% cross-reactivity with recombinant zebrafish VEGF is observed.

Human

IgG